Stock screener

COGT

Conviction 72HealthcareScan · Thu, Jun 25, 2026
COGT$38.00+1.25%
ResistanceSupportVol 14
63 bars
Vol MA14 3.19M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Cogent Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.cogentbio.com
Price38.00
Change+1.25%
Gap+0.00%
Rel volume3.37×
Avg volume3.09M
Avg $ vol106.93M
SMA 2033.82
SMA 5034.57
SMA 20031.57
Price vs 50+9.92%
Price vs 200+20.39%
MA stackbullish
50/200 cross
Supertrendup · 33.84
RSI (14)70
MACD hist0.70
MACD crossbull · 8d
Stoch %K / %D80 / 85
ADX (14)19
+DI / −DI36 / 12
RSI divergenceBullish
MACD divergenceBullish
ATR %+4.12%
ADR %4.51%
52w high42.11
52w low7.07
From 52w high-9.76%
Above 52w low+437.48%
New 52w highNo
SqueezeOff
Bollinger width23.45%
%B1.03
Donchian pos79.57%
Donchian high39.82
Donchian low30.93
AVWAP (52w high)36.39
vs AVWAP high+4.43%
AVWAP (52w low)27.01
vs AVWAP low+40.68%
OBV trendUp
Chaikin MF (20)-0.02
Today vs 20d3.37×
Avg vol (14d)3.19M
Avg vol (20d)3.09M
Avg $ vol (20d)106.93M
Market cap6.49B
RS 3m (vs SPY)-4.91%
RS 6m (vs SPY)-12.84%
RS line new highNo
Trend template6/8
Technical rank69.6
1 week+12.86%
1 month+11.96%
3 months+4.11%
6 months-3.41%
1 year+424.86%
YTD+9.38%
P/E-19.74
P/B10.68
P/S824.92
P/FCF-24.41
EPS-2.16
Div yield
ROE-54.13%
ROA-36.43%
Debt/Eq0.07
Current15.14
EV/EBITDA-19.03
Gross margin
Net margin
Rev growth0.00%
EPS growth-28.56%
Price target52.43
Target upside37.97%
Analyst ratingBuy
Institutional115.91%
Ent. value6.3B
Revenue312K
Net income-97.35M
Gross profit
Free cash flow-266M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out170.87M
Employees258
ListedThu, Mar 29, 2018
Free float134.64M
Float %83.0%
Short interest11.52M
Days to cover4.9d
Short volume50.6%
Squeeze score64 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.55 · 6 est
Last EPS vs est−$0.53 vs −$0.53
Last surprise0.0% beat
Setup gradeB
Conviction72 / 100
Pattern quality
Tech rank69.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance36.73
Support30.90
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in COGT

All disclosures →
No recent disclosed trades by Congress in COGT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in COGT · 1 buy · 1 sell

InsiderSideShares
Robbins Andrew R
President and CEO · Common Stock · 2026-05-19
Gift160K
Robbins Andrew R
President and CEO · Common Stock · 2026-05-19
Gift160K

SEC filings

EDGAR filings in COGT · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.